ID   APLP2_RAT               Reviewed;         765 AA.
AC   P15943;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   27-MAR-2024, entry version 154.
DE   RecName: Full=Amyloid beta precursor like protein 2 {ECO:0000312|RGD:2128};
DE   AltName: Full=Amyloid beta (A4) precursor-like protein 2 {ECO:0000250|UniProtKB:Q06335};
DE   AltName: Full=Amyloid protein homolog {ECO:0000305};
DE   AltName: Full=Amyloid-like protein 2 {ECO:0000312|RGD:2128};
DE            Short=APLP-2;
DE   AltName: Full=CDEI box-binding protein;
DE            Short=CDEBP;
DE   AltName: Full=Sperm membrane protein YWK-II {ECO:0000312|RGD:2128};
DE   Flags: Precursor;
GN   Name=Aplp2 {ECO:0000312|RGD:2128}; Synonyms=APPL2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-627.
RC   STRAIN=Wistar; TISSUE=Brain, and Heart;
RX   PubMed=8086458; DOI=10.1016/0167-4781(94)90263-1;
RA   Sandbrink R., Masters C.L., Beyreuther K.;
RT   "Complete nucleotide and deduced amino acid sequence of rat amyloid protein
RT   precursor-like protein 2 (APLP2/APPH): two amino acids length difference to
RT   human and murine homologues.";
RL   Biochim. Biophys. Acta 1219:167-170(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 575-765.
RC   TISSUE=Testis;
RX   PubMed=1690887; DOI=10.1073/pnas.87.7.2405;
RA   Yan Y.C., Bai Y., Wang L.F., Miao S.Y., Koide S.S.;
RT   "Characterization of cDNA encoding a human sperm membrane protein related
RT   to A4 amyloid protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2405-2408(1990).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May play a role in the regulation of hemostasis. The soluble
CC       form may have inhibitory properties towards coagulation factors. May
CC       interact with cellular G-protein signaling pathways. May bind to the
CC       DNA 5'-GTCACATG-3'(CDEI box). Inhibits trypsin, chymotrypsin, plasmin,
CC       factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn
CC       nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side
CC       chains in fibroblasts (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CPEB1. Interacts (via NPXY motif) with DAB2
CC       (via PID domain); the interaction is impaired by tyrosine
CC       phosphorylation of the NPXY motif (By similarity). Interacts (via
CC       cytoplasmic domain) with APBB2/FE65L (By similarity). Interacts (via
CC       intracellular domain) with APBB3/FE65L2 (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q06481}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=P15943-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P15943-2; Sequence=VSP_000021;
CC       Name=C;
CC         IsoId=P15943-3; Sequence=VSP_000020;
CC       Name=D;
CC         IsoId=P15943-4; Sequence=VSP_000020, VSP_000021;
CC   -!- SIMILARITY: Belongs to the APP family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01217}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X77934; CAA54906.1; -; mRNA.
DR   EMBL; M31322; AAA42352.1; -; mRNA.
DR   PIR; A35981; A35981.
DR   PIR; S42880; S42880.
DR   AlphaFoldDB; P15943; -.
DR   SMR; P15943; -.
DR   IntAct; P15943; 1.
DR   STRING; 10116.ENSRNOP00000067077; -.
DR   MEROPS; I02.016; -.
DR   GlyCosmos; P15943; 1 site, No reported glycans.
DR   GlyGen; P15943; 1 site.
DR   iPTMnet; P15943; -.
DR   PhosphoSitePlus; P15943; -.
DR   jPOST; P15943; -.
DR   PaxDb; 10116-ENSRNOP00000067835; -.
DR   AGR; RGD:2128; -.
DR   RGD; 2128; Aplp2.
DR   eggNOG; KOG3540; Eukaryota.
DR   InParanoid; P15943; -.
DR   PhylomeDB; P15943; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:P15943; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0097444; C:spine apparatus; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; ISO:RGD.
DR   GO; GO:0046914; F:transition metal ion binding; IEA:InterPro.
DR   GO; GO:0007409; P:axonogenesis; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0006878; P:intracellular copper ion homeostasis; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0007617; P:mating behavior; ISO:RGD.
DR   GO; GO:0030901; P:midbrain development; ISO:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0001967; P:suckling behavior; ISO:RGD.
DR   CDD; cd21709; JMTM_APLP2; 1.
DR   CDD; cd22607; Kunitz_ABPP-like; 1.
DR   Gene3D; 6.10.250.1670; -; 1.
DR   Gene3D; 1.20.120.770; Amyloid precursor protein, E2 domain; 1.
DR   Gene3D; 3.30.1490.140; Amyloidogenic glycoprotein, copper-binding domain; 1.
DR   Gene3D; 3.90.570.10; Amyloidogenic glycoprotein, heparin-binding domain; 1.
DR   Gene3D; 4.10.410.10; Pancreatic trypsin inhibitor Kunitz domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR036669; Amyloid_Cu-bd_sf.
DR   InterPro; IPR008155; Amyloid_glyco.
DR   InterPro; IPR011178; Amyloid_glyco_Cu-bd.
DR   InterPro; IPR024329; Amyloid_glyco_E2_domain.
DR   InterPro; IPR008154; Amyloid_glyco_extra.
DR   InterPro; IPR015849; Amyloid_glyco_heparin-bd.
DR   InterPro; IPR036454; Amyloid_glyco_heparin-bd_sf.
DR   InterPro; IPR019745; Amyloid_glyco_intracell_CS.
DR   InterPro; IPR019543; APP_amyloid_C.
DR   InterPro; IPR019744; APP_CUBD_CS.
DR   InterPro; IPR036176; E2_sf.
DR   InterPro; IPR002223; Kunitz_BPTI.
DR   InterPro; IPR036880; Kunitz_BPTI_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   PANTHER; PTHR23103; ALZHEIMER'S DISEASE BETA-AMYLOID RELATED; 1.
DR   PANTHER; PTHR23103:SF14; AMYLOID BETA PRECURSOR LIKE PROTEIN 2; 1.
DR   Pfam; PF10515; APP_amyloid; 1.
DR   Pfam; PF12924; APP_Cu_bd; 1.
DR   Pfam; PF12925; APP_E2; 1.
DR   Pfam; PF02177; APP_N; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00203; AMYLOIDA4.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00006; A4_EXTRA; 1.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF56491; A heparin-binding domain; 1.
DR   SUPFAM; SSF89811; Amyloid beta a4 protein copper binding domain (domain 2); 1.
DR   SUPFAM; SSF57362; BPTI-like; 1.
DR   SUPFAM; SSF109843; CAPPD, an extracellular domain of amyloid beta A4 protein; 1.
DR   PROSITE; PS00319; APP_CUBD; 1.
DR   PROSITE; PS51869; APP_E1; 1.
DR   PROSITE; PS51870; APP_E2; 1.
DR   PROSITE; PS00320; APP_INTRA; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Copper; Disulfide bond; Glycoprotein; Membrane;
KW   Metal-binding; Phosphoprotein; Protease inhibitor; Proteoglycan;
KW   Reference proteome; Serine protease inhibitor; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..765
FT                   /note="Amyloid beta precursor like protein 2"
FT                   /id="PRO_0000000209"
FT   TOPO_DOM        32..695
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        696..718
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        719..765
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          46..205
FT                   /note="E1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DOMAIN          308..366
FT                   /note="BPTI/Kunitz inhibitor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DOMAIN          375..566
FT                   /note="E2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01218"
FT   REGION          46..139
FT                   /note="GFLD subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   REGION          147..205
FT                   /note="CuBD subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   REGION          211..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          597..616
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          751..765
FT                   /note="Interaction with DAB2"
FT                   /evidence="ECO:0000250"
FT   MOTIF           752..757
FT                   /note="NPXY motif"
FT   COMPBIAS        215..234
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..272
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        273..288
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         163
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   BINDING         167
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   BINDING         184
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   SITE            186
FT                   /note="Required for Cu(2+) reduction"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   SITE            322..323
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         592
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06481"
FT   CARBOHYD        628
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06481"
FT   DISULFID        56..80
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        91..133
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        116..123
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        149..203
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        160..190
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        174..202
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01217"
FT   DISULFID        312..362
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        321..345
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        337..358
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   VAR_SEQ         311..365
FT                   /note="Missing (in isoform C and isoform D)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000020"
FT   VAR_SEQ         616..627
FT                   /note="Missing (in isoform B and isoform D)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000021"
FT   CONFLICT        575..577
FT                   /note="DQF -> EFV (in Ref. 2; AAA42352)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   765 AA;  86883 MW;  CF51FCCCE305A0CF CRC64;
     MAATGTAAAA ATGKLLVLLL LGLTAPAAAL AGYIEALAAN AGTGFAVAEP QIAMFCGKLN
     MHVNIQTGKW EPDPTGTKSC LGTKEEVLQY CQEIYPELQI TNVMEANQPV NIDSWCRRDK
     KQCRSHIVIP FKCLVGEFVS DVLLVPENCQ FFHQERMEVC EKHQRWHTVV KEACLTEGMT
     LYSYGMLLPC GVDQFHGTEY VCCPQTKVVD SDSTMSKEEE EEEEEDEEED YALDKSEFPT
     EADLEDFTEA AADEDEDEEE EEEEEGEEVV EDRDYYYDSF KGDDYNEENP TEPSSDGTIS
     DKEIAHDVKA VCSQEAMTGP CRAVMPRWYF DLSKGKCVRF IYGGCGGNRN NFESEDYCMA
     VCKTMIPPTP LPTNDVDVYF ETSADDNEHA RFQKAKEQLE IRHRSRMDRV KKEWEEAELQ
     AKNLPKAERQ TLIQHFQAMV KALEKEAASE KQQLVETHLA RVEAMLNDRR RIALENYLAA
     LQSDPPRPHR ILQALRRYVR AENKDRLHTI RHYQHVLAVD PEKAAQMKSQ VMTHLHVIEE
     RRNQSLSLLY KVPYVAQEIQ EEIDELLQEQ RADMDQFTSS ISENPVDVRV SSEESEEIPP
     FHPFHPFPSL SENEDTQPEL YHPMKKGSGM AEQDGGLIGA EEKVINSKNK MDENMVIDET
     LDVKEMIFNA ERVGGLEEEP DSVGPLREDF SLSSSALIGL LVIAVAIATV IVISLVMLRK
     RQYGTISHGI VEVHPMLTPE ERHLNKMQNH GYENPTYKYL EQMQI
//
